Spain· ES:181289001IP
BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing emtricitabina + tenofovir alafenamida + bictegravir, registered in Spain by Gilead Sciences Ireland Unlimited Company.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- emtricitabina + tenofovir alafenamida + bictegravir
- Manufacturer
- Gilead Sciences Ireland Unlimited Company
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabina + tenofovir alafenamida + bictegravir in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBiktarvyGilead Sciences, Inc.
- FinlandBiktarvyGilead Sciences Ireland UC
- CzechiaBIKTARVYGilead Sciences Ireland UC, Carrigtohill
- FranceBIKTARVY 30 mg/120 mg/15 mg, comprimé pelliculéGILEAD SCIENCES IRELAND UC (IRLANDE)
- IrelandBiktarvy 30 mg/120 mg/15 mg Film-coated tabletGilead Sciences Ireland UC
- IcelandBiktarvyGilead Sciences Ireland UC*
- NorwayBiktarvyGilead Sciences Ireland UC
- PolandBiktarvyGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Biktarvy
- Liechtenstein · Biktarvy
- Norway · Biktarvy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/678c2ce5-0298-4157-83c6-f72ee7fa9d37 GET /v1/drugs/678c2ce5-0298-4157-83c6-f72ee7fa9d37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1652802037000}",
"nregistro": "181289001IP",
"substance": "emtricitabina + tenofovir alafenamida + bictegravir"
}See everything about emtricitabina + tenofovir alafenamida + bictegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.